MonTa Biosciences ApS: Financial statements 2025
CVR: 36697016
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
MonTa Biosciences ApS (CVR 36697016) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,811,082 and a net result of DKK -4,776,853 compared with DKK -3,920,572 the year before. That is an increase of 22.4% compared with the year before. Equity in the 2025 report amounted to DKK -10,304,549. The company had 3 employees in the financial year.
- Gross Profit
- DKK 1,811,082
- Profit/Loss
- DKK -4,776,853
- Equity
- DKK -10,304,549
- Total Assets
- DKK 103,651,893
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.8 mio. | -4.8 mio. | -10.3 mio. | 3 |
| 2024 | - | 1.5 mio. | -3.9 mio. | -5.5 mio. | 3 |
| 2023 | - | 2 mio. | -3.3 mio. | -1.6 mio. | 4 |
| 2022 | - | 1.8 mio. | -1.4 mio. | 1.7 mio. | 3 |
| 2021 | - | 2.1 mio. | 1.4 mio. | 3.1 mio. | 3 |
Official annual report
How creditworthy is MonTa Biosciences ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of June 30, 2025, Søren Tulstrup has joined the board of directors of MonTa Biosciences ApS.
As of June 23, 2025, Peter Birk Rasmussen has left the board of directors of MonTa Biosciences ApS.
MonTa Biosciences ApS has published its annual report for 2024. Gross profit came to DKK 1,479,565, and the net result was DKK -3,920,572.
About MonTa Biosciences ApS
MonTa Biosciences ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named MonTa Biosciences IVS. The management consists of Simon Skjøde Jensen. The board consists of Lone Schøtt Kunøe (chair), Esper Boel, Sven Madsen and Søren Tulstrup. The company's owners include Jonas Rosager Henriksen, TLA-HOLDING 2010 ApS and JENSEN BIOCONSULT ApS. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 1,811,082 and a net result of DKK -4,776,853 compared with DKK -3,920,572 the year before. Equity in the 2025 report amounted to DKK -10,304,549.